Results 121 to 130 of about 100,614 (290)

Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: A prospective randomized trial in Algeria

, 2010
Mourad Aribi, Naïma Mesli, Nesrine Remla, Badr-Eddine Sari, Abdesselam Taleb, Hadj Touhami, Mohamed‐Amine Bekadja, Z. Zouaoui‐Benhadji, Kamel Bouzid, Kaoual Meguenni   +9 more
openalex   +1 more source

Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To compare cochlear dose and hearing outcomes between intensity‐modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) in patients with nasopharyngeal carcinoma (NPC). Study Design Prospective matched cohorts. Setting Tertiary academic center.
Kuang‐Hsu Lien, Chien‐Yu Lin, Po‐Yuan Chen, Joseph Tung‐Chieh Chang, Tai‐Yu Chen, Sheng‐Ping Hung, Ching‐Hsin Lee, Wing‐Keen Yap, Cheng‐En Hsieh, Cheng‐Lung Hsu, Chi‐Yin Lee, Kai‐Ping Chang   +11 more
wiley   +1 more source

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

, 2016
Kwang Hyun Chung, Ji Kon Ryu, Jun Hyuk Son, Jae W. Lee, Dong Kee Jang, Sang Hyub Lee, Yong‐Tae Kim   +6 more
openalex   +2 more sources

Risk of metachronous upper tract urothelial carcinoma following non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objective To determine the risk and timing of metachronous upper tract urothelial carcinoma (UTUC) after non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods In this multi‐institutional retrospective cohort study involving academic and community hospitals, clinicopathological data were collected from patients with NMIBC treated between 2005
Keiran J.C. Pace, Jethro C.C. Kwong, Harkanwal Randhawa, Maximiliano Ringa, Zizo Al‐Daqqaq, Yashan Chelliahpillai, Soomin Lee, Kellie Kim, Samuel Haile, Amna Ali, Marian Wettstein, Amy Chan, Nathan Perlis, Jason Lee, Robert Hamilton, Neil Fleshner, Antonio Finelli, Munir Jamal, Frank Papanikolaou, Thomas Short, Andrew Feifer, Girish Kulkarni, Alexandre R. Zlotta   +22 more
wiley   +1 more source

Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer. [PDF]

BJU Int
Objectives To develop a drug‐releasing intravesical floating technology (DRIFT) device for controlled sequential delivery of gemcitabine and docetaxel (Gem/Doce) to optimise the treatment of non‐muscle‐invasive bladder cancer (NMIBC) while enabling patient mobility and self‐removal, as sequential intravesical Gem/Doce has been increasingly utilised but
Rhodes AC, McClintic KA, Witt E, Nwosu I, Balk KR, Reis C, Sutton IC, Bi J, Fu MZ, O'Donnell MA, Packiam VT, Byrne JD.   +11 more
europepmc   +2 more sources

Opioids in breast cancer: Between analgesia and modulation of tumour progression

British Journal of Pharmacology, EarlyView.
Preclinical investigations consistently demonstrate that activation of μ‐opioid receptors and δ‐opioid receptors promote proliferation, migration, angiogenesis, epithelial‐mesenchymal transition, acquisition of cancer stem cell phenotypes, and chemoresistance.
Marianna Ciwun, Anna Tankiewicz‐Kwedlo, Dariusz Pawlak   +2 more
wiley   +1 more source

Updated results of biweekly gemcitabine/nab-paclitaxel as first-line treatment for advanced pancreatic cancer

, 2018
Stefania Kokkali, Maria Drizou, Elli Tripodaki, Dimitra Stefanou, Elpida Magou, Dimosthenis Zylis, Matthaios Kapiris, Despoina Nasi, C. Georganta, Alexandros Ardavanis   +9 more
openalex   +1 more source

204. Gene Therapy of Pancreatic Carcinoma Based on Gemcitabine Chemosensitization Using Phosphorylating Fusion Gene Transfer [PDF]

, 2007

openalex   +1 more source

Targeting Genome Maintenance Defects of Cancers Using Chain‐Terminating Nucleoside Analogs

Cancer Science, EarlyView.
Nucleoside analogs interfere with DNA replication either by their chain‐terminating properties or by serving as DNA damage on the template. The genome maintenance pathways required to maintain cellular tolerance to each nucleoside analog vary depending on the drug.
Ryotaro Kawasumi, Rubaiat E. Tabassum, Kouji Hirota   +2 more
wiley   +1 more source

<p>Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response</p>. [PDF]

Int J Oncol
Sekiguchi N, Takahashi H, Kobayashi S, Sasaki K, Hasegawa S, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Asaoka T, Noda T, Shimizu J, Tanaka K, Chijimatsu R, Doki Y, Eguchi H.   +15 more
europepmc   +1 more source